Movano

Crusader Vans Announce Economic Leasing Options For Vauxhall’s New Vivaro And Movano Vans

Retrieved on: 
Wednesday, November 1, 2023

Buxted, United Kingdom, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Crusader Vans, a leading van leasing company operating in East Sussex, England, for the past 19 years, is excited to announce a range of economic leasing options for Vauxhall’s new Vivaro van and Movano van.

Key Points: 
  • Buxted, United Kingdom, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Crusader Vans, a leading van leasing company operating in East Sussex, England, for the past 19 years, is excited to announce a range of economic leasing options for Vauxhall’s new Vivaro van and Movano van.
  • The Vauxhall vans currently available for lease at Crusader Vans include:
    The Vauxhall Combo: Designed for those looking for a small car-derived van for small jobs.
  • The Vauxhall Movano: For those who need larger vans for bigger jobs but want the same style and drivability as smaller vans.
  • For more information on Crusader Vans and its leasing options for Vauxhall’s new Vivaro van and Movano van, please visit https://www.crusader-vans.co.uk/ .

Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results

Retrieved on: 
Monday, March 20, 2023

PLEASANTON, Calif., March 20, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months and year ending December 31, 2022 and provided a business update.

Key Points: 
  • Key highlights from the fourth quarter and recent weeks include:
    Movano Health continues to progress toward the summer 2023 launch of its first commercial product, the Evie Ring.
  • Movano Health details more information on the key highlights from the fourth quarter and recent weeks below:
    Movano Health continues to progress toward the summer 2023 launch of its first commercial product, the Evie Ring.
  • The Company reported an operating loss of $8.0 million in the fourth quarter of 2022 compared to an operating loss of $6.3 million in the fourth quarter of 2021.
  • As such, the Company did not generate revenue in either the fourth quarter of 2022 or the fourth quarter of 2021.

Movano Health Completes $7.5 Million Public Offering

Retrieved on: 
Monday, February 6, 2023

The public offering price, before the underwriters' discount and commissions, for each share of common stock and accompanying warrant was $1.40.

Key Points: 
  • The public offering price, before the underwriters' discount and commissions, for each share of common stock and accompanying warrant was $1.40.
  • All of the securities in the underwritten public offering were sold by Movano Inc.
  • The Company intends to use the net proceeds from the offering for general corporate purposes, which may include funding product development and commercialization activities.
  • A preliminary prospectus supplement relating to the offering has been filed with the SEC and is available on the SEC's website at http://www.sec.gov .

Movano Health Prices $6.5 Million Public Offering

Retrieved on: 
Friday, January 27, 2023

PLEASANTON, Calif., Jan. 27, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase up to 2,322,000 shares of common stock.

Key Points: 
  • PLEASANTON, Calif., Jan. 27, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase up to 2,322,000 shares of common stock.
  • The public offering price, before the underwriters' discount and commissions, for each share of common stock and accompanying warrant is $1.40.
  • All of the securities in the underwritten public offering were sold by Movano Inc.
  • The Company has granted the underwriter a 30-day option to purchase up to an additional 15% of shares of common stock and/or warrants to purchase shares of common stock sold in the offering at the public offering price, less the underwriting discount.